The role of WT1 gene in neuroblastoma

Journal of Pediatric Surgery

Volumn 46, Issue 2, 2011, Pages 326-331

  Wang, Jingfu ^a   Oue, Takaharu ^b   Uehara, Shuichiro ^b   Yamanaka, Hiroaki ^b   Oji, Yusuke ^b   Fukuzawa, Masahiro ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Ganglioneuroma; Neuroblastoma; Proliferation; Suppression; WT1

Indexed keywords

MESSENGER RNA;

ARTICLE; CANCER GRADING; CELL MATURATION; CELL PROLIFERATION; GANGLIONEUROMA; GENE EXPRESSION; GENE FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GENE; TUMOR GROWTH; WT1 GENE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; GANGLIONEUROBLASTOMA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, WILMS TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; ONCOGENES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; WT1 PROTEINS;

EID: 79551606230     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2010.11.011     Document Type: Article

References (27)

1. Haber D.A., Buckler A.J., and Glaser T. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor Cell 61 1990 1257 1269
2. Menssen H.D., Renkl H.J., and Rodeck U. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias Leukemia 9 1995 1060 1067
3. Koesters R., Linnebacher M., and Coy J.F. WT1 is a tumor-associated antigen in colon cancer that can be recognized by in vitro stimulated cytotoxic T cells Int J Cancer 109 2004 385 392
4. Amini Nik S., Hohenstein P., and Jadidizadeh A. Upregulation of Wilms' tumor gene 1 (WT1) in desmoid tumors Int J Cancer 114 2005 202 208
5. Oji Y., Suzuki T., and Nakano Y. Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors Cancer Sci 95 2004 822 827
6. Oka Y., Tsuboi A., and Taguchi T. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression Proc Natl Acad Sci U S A 101 2004 13885 13890
7. Maris J.M., Hogarty M.D., and Bagatell R. Neuroblastoma Lancet 369 2007 2106 2120
8. Nakatsuka S., Oji Y., and Horiuchi T. Immunohistochemical detection of WT1 protein in a variety of cancer cells Mod Pathol 19 2006 804 814
9. Anuchapreeda S., Tima S., and Duangrat C. Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines Cancer Chemother Pharmacol 62 2008 585 594
10. Oji Y., Miyoshi S., and Maeda H. Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers Int J Cancer 100 2002 297 303
11. Little M., and Wells C. A clinical overview of WT1 gene mutations Hum Mutat 9 1997 209 225
12. Little M.H., Williamson K.A., and Mannens M. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion Hum Mol Genet 2 1993 259 264
13. Smith S.I., Down M., and Boyd A.W. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice Cancer Res 60 2000 808 814
14. Fraizer G., Leahy R., and Priyadarshini S. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene Int J Oncol 24 2004 461 471
15. Haber D.A., Park S., and Maheswaran S. WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant Science 262 1993 2057 2059
16. McMaster M.L., Gessler M., and Stanbridge E.J. WT1 expression alters tumorigenicity of the G401 kidney-derived cell line Cell Growth Differ 6 1995 1609 1617
17. Menke A.L., Shvarts A., and Riteco N. Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor Cancer Res 57 1997 1353 1363
18. Harada Y., Nonomura N., and Nishimura K. WT1 gene expression in human testicular germ-cell tumors Mol Urol 3 1999 357 364
19. Inoue K., Sugiyama H., and Ogawa H. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia Blood 84 1994 3071 3079
20. Miyoshi Y., Ando A., and Egawa C. High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients Clin Cancer Res 8 2002 1167 1171
21. Yamagami T., Sugiyama H., and Inoue K. Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis Blood 87 1996 2878 2884
22. Algar E.M., Khromykh T., and Smith S.I. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines Oncogene 12 1996 1005 1014
23. Dennis S.L., Manji S.S., and Carrington D.P. Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors Int J Cancer 97 2002 713 715
24. Wagner N., Wagner K.D., and Schley G. The Wilms' tumor suppressor Wt1 is associated with the differentiation of retinoblastoma cells Cell Growth Differ 13 2002 297 305
25. Wagner N., Wagner K.D., and Hammes A. A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system Development 132 2005 1327 1336
26. Scharnhorst V., Kranenburg O., and van der Eb A.J. Differential regulation of the Wilms' tumor gene, WT1, during differentiation of embryonal carcinoma and embryonic stem cells Cell Growth Differ 8 1997 133 143
27. Oka Y., Tsuboi A., and Oji Y. WT1 peptide vaccine for the treatment of cancer Curr Opin Immunol 20 2008 211 220